Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zenyth Therapeutics Ltd.

Division of CSL Ltd.
www.zenyth.com.au

Latest From Zenyth Therapeutics Ltd.

UK Stem Cell IPOs Defy Odds

When ReNeuron Ltd. announced its intention to float on London's Alternative Investment Market (AIM) in July, most onlookers gave a sceptical laugh. But the subsequent IPO, although small, showed that even risky, pre-clinical bets can float--if they're priced low enough.
BioPharmaceutical Europe

Jumpstart to Products

Discovery research is an ever more difficult investment to justify, so companies are placing greater emphasis on mining discoveries that have already been made but whose real value remains unexploited. Big Pharma, in part inhibited by habit and current infrastructure, has not moved aggressively in the new direction-but the jumpstart model now dominates small-company strategies and will increasingly translate into the rest of the industry.
BioPharmaceutical Strategy

Cerylid Biosciences Ltd.

Cerylid Biosciences Ltd. is tapping the pharmaceutical potential in a collection of some 600,000 extracts of plants, microbes, and marine macroorganisms from Australia and South East Asia. The firm says it has identified nearly 350 active molecules, and has taken three into development. The company is keen to expose its libraries to good targets, and so is seeking partners.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Amrad Corp. Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • CSL Ltd.
  • Senior Management
  • Jonathan Coates, PhD, CSO
    Alan Boyd, Dir., Fin. & Admin.
  • Contact Info
  • Zenyth Therapeutics Ltd.
    Phone: (61) 392084000
    567 Swan St.
    ABN 37 006 614
    Richmond, 3121
    Australia
UsernamePublicRestriction

Register